For patients considering alternatives to spinal fusion, non-surgical options like biologic disc repair and intra-annular fibrin injection may offer meaningful pain relief and preserved mobility. Recovery timelines and outcomes vary by individual — this guide explains what the post-treatment process may look like.

Microdiscectomy and non-surgical disc treatments each address different aspects of disc-related pain, and the right path depends on the individual patient's diagnosis, imaging findings, and treatment history. This guide reviews how each approach works, what risks and limitations to consider, and how candidacy for biologic disc repair is evaluated.

Compare laminectomy and regenerative spine care for spinal stenosis — including intra-annular fibrin injection and biologic disc repair — so you can evaluate which path fits your individual situation and ask the right questions before committing to any treatment.

Learn how to return to activity after intra-annular fibrin injection or biologic disc repair. This phase-by-phase guide covers what to expect from the first week through long-term wellness — with individualized guidance from our clinical team at ValorSpine.

Degenerative disc disease does not follow a single treatment path. For some individuals, biologic disc repair and other non-surgical approaches offer meaningful alternatives to spinal fusion — though candidacy depends on each person's anatomy, diagnosis, and prior treatment history.

Lumbar spine pain stems from several diagnosable conditions — annular tears, disc degeneration, herniation, and facet arthritis among them. Accurate diagnosis is the critical first step. For many patients, non-surgical alternatives to spinal fusion, including biologic disc repair using intra-annular fibrin injection, offer a meaningful path forward. Candidacy is evaluated individually and outcomes vary by case.

Compare intra-annular fibrin injection to traditional spine surgeries. Explore how each approach works, their risk profiles, recovery expectations, and how candidacy is determined for biologic disc repair.